Lymphoma Phase III MabCute Study: Subcutaneous Rituximab in Patients with R/R Indolent Non-Hodgkin Lymphoma Apr 17, 2023
Lymphoma Phase 3 GOYA Trial: Obinutuzumab and CHOP versus Rituximab and CHOP for Diffuse Large B-Cell Lymphoma Apr 17, 2023
Lymphoma Phase 2 IELSG32 Trial: Advancing Treatment for Primary Central Nervous System Lymphoma Apr 17, 2023
Lymphoma Copanlisib and Rituximab Combination Therapy in iNHL: Chronos-3 Phase III Trial Apr 17, 2023
Lymphoma Phase 3 Bruin CLL-322 Trial: Investigating the Efficacy of Pirtobrutinib in CLL/SLL Treatment Apr 17, 2023
Lymphoma Phase 3 Trial Comparing Zanubrutinib and Ibrutinib in Patients with WM ASPEN Study Apr 17, 2023
Lymphoma Efficacy and Safety of Axicabtagene Ciloleucel in First-Line Therapy: Phase 2 ZUMA-12 Study Apr 17, 2023
